[1]
|
M. Van de Wouwer, D. Collen and E. M. Conway, “Thrombomodulin-Protein C-EPCR System: Integrated to Regulate Coagulation and Inflammation,” Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 24, 2004, pp. 1374-1383. http://dx.doi.org/10.1161/01.ATV.0000134298.25489.92
|
[2]
|
H. Saito, I. Maruyama, S. Shimazaki, Y. Yamamoto, N. Akikawa, R. Ohno, A. Hirayama, T. Matsuda, H. Asakura, M. Nakashima and N. Aoki, “Efficacy and Safety of Recombinant Human Soluble Thrombomodulin (ART-123) in Disseminated Intravascular Coagulation: Results of a Phase III, Randomized, Double-Blind Clinical Trial,” Journal of Thrombosis and Haemostasis, Vol. 5, No. 1, 2007, pp. 31-41. http://dx.doi.org/10.1111/j.1538-7836.2006.02267.x
|
[3]
|
S. C. Sebag, J. A. Bastarache and L. B. Ware, “Therapeutic Modulation of Coagulation and Fibrinolysis in Acute Lung Injury and the Acute Respiratory Distress Syndrome,” Current Pharmaceutical Biotechnology, Vol. 12, No. 9, 2011, pp. 1481-1496. http://dx.doi.org/10.2174/138920111798281171
|
[4]
|
J. H. Finigan, “The Coagulation System and Pulmonary Endothelial Function in Actre Lung Injury,” Microvascular Research, Vol. 77, No. 1, 2009, pp. 35-38. http://dx.doi.org/10.1016/j.mvr.2008.09.002
|
[5]
|
H. Lum and A. B. Malik, “Regulation of Vascular Endothelial Barrier Function,” American Journal of Physiology —Lung Cellular and Molecular Physiology, Vol. 267, 1994, pp. L233-241.
|
[6]
|
G. Cirino, C. Cicala, M. R. Bucci, L. Sorrentino, J. M. Maraganore, and S. R. Stone, “Thrombin Functions as an Inflammatory Mediator through Activation of Its Receptor,” The Journal of Experimental Medicine, Vol. 183, No. 3, 1996, pp. 821-827. http://dx.doi.org/10.1084/jem.183.3.821
|
[7]
|
The ARDS Definition Task Force, “Acute Respiratory Distress Syndrome Berlin Definition,” JAMA, Vol. 307, No. 23, 2012, pp. 1-8. http://dx.doi.org/10.1001/jama.2012.5669
|
[8]
|
K. D. Liu, J. Levitt, H. Zhuo, R. H. Kallet, S. Brady, J. Steingrub, M. Tidswell, M. D. Siegel, G. Soto, M. W. Peterson, M. S. Chesnutt, C. Phillips, A. Weinacker, B. T. Thompson, M. D. Eisner and M. A. Matthay, “Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung Injury,” American Journal of Respiratory and Critical Care Medicine, Vol. 178, No. 6, 2008, pp. 618-623. http://dx.doi.org/10.1164/rccm.200803-419OC
|
[9]
|
M. Mohri, Y. Gonda, M. Oka, Y. Aoki, K. Gomi, T. Kiyota, T. Sugihara, S. Yamamoto, T. Ishida and I. Maruyama, “The Antithrombotic Effects of Recombinant Human Soluble Thrombomodulin (rhsTM) on Tissue Factor-Induced Disseminated Intravascular Coagulation in Crab-Eating Monkeys (Macaca fascicularis),” Blood Coagul Fibrinolysis, Vol. 8, 1997, pp. 274-283. http://dx.doi.org/10.1097/00001721-199707000-00003
|
[10]
|
K. Abeyama, D. M. Stern, Y. Ito, K. Kawahara, Y. Yoshimoto, M. Tanaka, T. Uchimura, N. Ida, Y. Yamazaki, S. Yamada, Y. Yamamoto, H. Yamamoto, S. Iino, N. Taniguchi and I. Maruyama, “The N-Terminal Domain of Thrombomodulin Sequesters High-Mobility Group-B1 Protein, a Novel Antiinflammatory Mechanism,” Journal of Clinical Investigation, Vol. 115, No. 5, 2005, pp. 1267-1274.
|
[11]
|
C. S. Shi, G. Y. Shi, S. M. Hsiao, Y. C. Kao, K. L. Kuo, C. Y. Ma, C. H. Kuo, B. I. Chang, C. F. Chang, C. H. Lin, C. H. Wong and H. L. Wu, “Lectin-Like Domain of Thrombomodulin Binds to Its Specific Ligand Lewis Y Antigen and Neutralizes Lipopolysaccharide-Induced Inflammatory Response,” Blood, Vol. 112, No. 9, 2008, pp. 3661-3670.
|
[12]
|
M. Van de Wouwer, S. Plaisance, A. De Vriese, E. Waelkens, D. Collen, J. Persson, M. R. Daha and E. M. Conway, “The Lectin-Like Domain of Thrombomodulin Interferes with Complement Activation and Protects against Arthritis,” Journal of Thrombosis and Haemostasis, Vol. 4, No. 8, 2006, pp. 1813-1824.
|
[13]
|
M. Nagato, K. Okamoto, Y. Abe, A. Higure and K. Yamaguchi, “Recombinant Human Soluble Thrombomodulin Decreases the Plasma High-Mobility Group Box-1 Protein Levels, Whereas Improving the Acute Liver Injury and Survival Rates in Experimental Endotoxemia,” Critical Care Medicine, Vol. 37, No. 7, 2009, pp. 2181-2186.
|
[14]
|
E. Abraham, J. Arcaroli, A. Carmody, H. Wang and K. J. Tracey, “HMG-1 as Mediator of Acute Lung Inflammation,” The Journal of Immunology, Vol. 165, No. 6, 2000, pp. 2950-2954.
|
[15]
|
A. Ishizaka, T. Matsuda, K. H. Albertine, H. Koh, S. Tasaka, N. Hasegawa, N. Kohno, T. Kotani, H. Morisaki, J. Takeda, M. Nakamura, X. Fang, T. R. Martin, M. A. Matthay and S. Hashimoto, “Elevation of KL-6, a Lung Epithelial Cell Marker, in Plasma and Epithelial Lining Fluid in Acute Respiratory Distress Syndrome,” American Journal of Physiology—Lung Cellular and Molecular Physiology, Vol. 286, 2004, pp. L1088-1094.
|
[16]
|
P. J. Offner and E. E. Moore, “Lung Injury Severity Scoring in the Era of Lung Protective Mechanical Ventilation: The PaO2/FIO2 Ratio,” Journal of Trauma, Vol. 55, No. 2, 2003, pp. 285-289.
|